Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
AbbVie
ABBV
|
+$384M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Intuit
INTU
|
+$350M |
| 4 |
ICU Medical
ICUI
|
+$295M |
| 5 |
Netflix
NFLX
|
+$287M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
+$673M |
| 2 |
American Tower
AMT
|
+$538M |
| 3 |
Apple
AAPL
|
+$456M |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$436M |
| 5 |
Meta Platforms (Facebook)
META
|
+$384M |
Sector Composition
| 1 | Technology | 23.85% |
| 2 | Healthcare | 17.84% |
| 3 | Financials | 12.82% |
| 4 | Industrials | 11.63% |
| 5 | Consumer Discretionary | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
BWX Technologies
BWXT
$14.8B
| $75.6M | 0.05% |
1,977,701
+166,691
| +9% | +$6.37M |
|
427
Rollins
ROL
$27.7B
| $75.5M | 0.05% |
3,137,879
+1,703,774
| +119% | +$41M |
|
428
Cheniere Energy
LNG
$52B
| $75.5M | 0.05% |
1,275,684
+298,478
| +31% | +$17.7M |
|
429
Burlington
BURL
$17.8B
| $75.5M | 0.05% |
464,092
+176,858
| +62% | +$28.8M |
|
|
MRO
430
DELISTED
Marathon Oil Corporation
MRO
| $75.5M | 0.05% |
5,264,103
+890,391
| +20% | +$12.8M |
|
431
Lamb Weston
LW
$8.03B
| $75.4M | 0.05% |
1,025,673
-225,361
| -18% | -$16.6M |
|
432
Kosmos Energy
KOS
$780M
| $75.3M | 0.05% |
18,570,000
+3,040,000
| +20% | +$12.3M |
|
433
LendingTree
TREE
$982M
| $75.1M | 0.05% |
342,067
+17,211
| +5% | +$3.78M |
|
|
CISN
434
DELISTED
Cision Ltd. Ordinary Share
CISN
| $74.7M | 0.05% |
6,381,852
+3,704,028
| +138% | +$43.3M |
|
435
NeoGenomics
NEO
$1.02B
| $74.3M | 0.05% |
5,888,667
-215,808
| -4% | -$2.72M |
|
|
XEC
436
DELISTED
CIMAREX ENERGY CO
XEC
| $74.1M | 0.05% |
1,201,569
+85,178
| +8% | +$5.25M |
|
437
Nomad Foods
NOMD
$2.13B
| $74M | 0.05% |
4,427,646
+8,878
| +0.2% | +$148K |
|
438
Universal Health Services
UHS
$11.8B
| $73.5M | 0.05% |
630,620
+5,852
| +0.9% | +$682K |
|
|
EGRX
439
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $72.3M | 0.05% |
1,795,462
-86,039
| -5% | -$3.47M |
|
440
Generac Holdings
GNRC
$10.6B
| $71.3M | 0.05% |
1,434,892
-222,798
| -13% | -$11.1M |
|
441
Collegium Pharmaceutical
COLL
$1.19B
| $71.3M | 0.05% |
4,151,719
+31,896
| +0.8% | +$548K |
|
442
CGI
GIB
$21.4B
| $70.9M | 0.05% |
1,159,108
+626,237
| +118% | +$38.3M |
|
443
Conagra Brands
CAG
$9.28B
| $70.5M | 0.05% |
3,301,914
+1,091,137
| +49% | +$23.3M |
|
444
Dorman Products
DORM
$4.97B
| $70.4M | 0.04% |
782,451
-9,321
| -1% | -$839K |
|
445
Goldman Sachs
GS
$231B
| $70.4M | 0.04% |
421,351
-313,276
| -43% | -$52.3M |
|
446
Sempra
SRE
$52.6B
| $69.9M | 0.04% |
1,292,574
+563,062
| +77% | +$30.5M |
|
447
AMC Entertainment Holdings
AMC
$1.44B
| $69.7M | 0.04% |
567,234
+90,461
| +19% | +$11.1M |
|
|
JWN
448
DELISTED
Nordstrom
JWN
| $69.4M | 0.04% |
1,487,948
+1,239,905
| +500% | +$57.8M |
|
449
Wave Life Sciences
WVE
$1.2B
| $69M | 0.04% |
1,641,194
+124,414
| +8% | +$5.23M |
|
450
Ironwood Pharmaceuticals
IRWD
$185M
| $68.9M | 0.04% |
7,945,838
-1,590,371
| -17% | -$13.8M |
|